Comorbidity in context: Part 2. Ethicolegal considerations around HIV and tuberculosis during the COVID-19 pandemic in South Africa by Rossouw, T M et al.
1       Published online ahead of print
IN PRACTICE
The advent of the COVID-19 pandemic has sparked widespread 
debate about the appropriate and fair rationing of scarce resources. 
Personal protective equipment is in short supply and access to 
intensive care units (ICUs) and ventilators is limited.[1] This scenario 
has played out all over the world, with even the best-resourced 
countries unable to meet the demand for ICU admission and 
ventilation due to SARS-CoV-2 infection. Critical care triaging has 
become a reality. The World Health Organization has warned that 
Africa could be the next epicentre of the pandemic.[2] Given the 
likelihood that the worst-off in society will be disproportionately 
affected by large COVID-19 outbreaks, it is important to pay 
attention to the ethical and human rights considerations, with 
particular reference to individuals who are vulnerable.
This is the second in a series of two articles focusing on individuals 
with HIV or tuberculosis (TB) infection. These groups are specifically 
discussed owing to their increased vulnerability, which stems not 
only from their possible susceptibility to SARS-CoV-2 infection, 
but also from their exposure to discrimination, marginalisation, 
and denial of their rights.[3-6] Since patients with HIV or TB may 
potentially be excluded from admission to an ICU on the basis of 
an assumption of lack of clinical suitability for critical care, the first 
article argued that there is currently no evidence that uncomplicated 
HIV and TB per se should disqualify a person from admission to an 
ICU. This article outlines the ethicolegal implications of limiting ICU 
access of persons living with HIV and TB.
Estimating the size of the problem
Estimates for hospitalisation and ventilation due to COVID-19 vary 
across the world. A review of data from China reported that ~20% 
of patients with COVID-19 require inpatient care, with roughly 15% 
having severe symptoms and 5% needing mechanical ventilation.[7] 
Reports from Italy and Spain put hospitalisation and ICU admission 
proportions at 40 - 55% and 7 - 12%, respectively.[8] While the 
majority of patients require ~13 days of respiratory support,[9] some 
may need ventilation for several weeks.[10]
There is very little publicly available information regarding 
critical care resources in Africa. A systematic review found that 
>50% of included lower-income countries lacked any published 
data on ICU resources relative to their population.[11] Based on 
limited data, most African countries are estimated to have 5 ICU 
beds per million people, compared with 4 000 beds per million 
people in Europe.[12] While up-to-date and accurate numbers are 
difficult to find, SA appears to be slightly better off than other 
African countries and has been reported to have 7 195 ICU beds 
(2 238 in the public and 4 957 in the private sector) for its 59 million 
people.[13] At a ratio of 122 beds per million people, this is still 
well below what will be needed if a large proportion (estimated to 
potentially be 60%)[14] of the population becomes infected within a 
short period of time. In addition, the mere presence of ICU facilities 
does not necessarily imply adequate capacity for critical care. There 
is also a dire shortage of trained critical care specialists and nursing 
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staff, which will limit the capacity to treat critically ill patients even 
further.[15]
Many South Africans have risk factors associated with worse 
COVID-19 outcomes: ~13% of female and 9.7% of male adults have 
diabetes, and 8.1% of females and 33% of males smoke.[16] A nationally 
representative survey of people aged ≥50 years found that 77.9% (95% 
confidence interval (CI) 76.4 - 79.4) had hypertension. Only 38% 
(95% CI 36.2 - 39.8) were aware of their condition, and only 7.8% 
(95% CI 6.8 - 8.8) achieved optimal blood pressure targets. [17] Apart 
from these known risk factors, it is speculated that infection with 
HIV and TB may increase the risk of SARS-CoV-2 infection and poor 
outcome of COVID-19. In this context, it is sobering to consider that 
SA has one of the largest burdens of disease in the world, with an HIV 
prevalence of 19% (among 15 - 49-year-olds) and a TB incidence of 
301/100 000 (uncertainty interval 215 - 400).[16] This high level of 
vulnerability is concerning as we enter the annual influenza season, 
which traditionally places increased demands on ICU admissions and 
disproportionately affects immunocompromised people, especially 
those with HIV[18] and TB.[19] Rationing of ICU admission and care 
will be inevitable.
Legal considerations
The allocation and rationing of scarce healthcare resources must 
be done in terms of SA law. The Constitution of South Africa[20] 
and specifically the Bill of Rights guarantee the right of ‘access to 
health care services’ in section 27(1)(a). Of course, this guarantee 
is not absolute: it is impossible in a developing country such as 
SA to provide for everyone’s needs, and therefore limitations are 
placed on the right in terms of section 27(2) of the Constitution and 
in accordance with the general limitations clause in section 36. It 
should be remembered that the right of access to healthcare services 
should not be seen in isolation, as many rights in the Bill of Rights 
bear on the rationing of scare resources. Examples are the right to 
equality (section 9), dignity (section 10), life (section 11) and physical 
integrity (section 12).
Section 27(2) of the Constitution enjoins the state to ‘take 
reasonable legislative and other measures, within its available 
resources, to achieve the progressive realisation of each of these rights’ 
(our italics). The right of access to healthcare services, therefore, is 
realisable only over time and in accordance with the state’s resources. 
However, the right to emergency healthcare services is not subject to 
limitation – it appears to be immediately enforceable. According to 
section 27(3), no one ‘may be refused emergency medical treatment’, 
which is not defined either in legislation or in case law. Such a 
definition is urgently needed, and more conceptual work needs to 
be undertaken on what exactly constitutes ‘emergency’ healthcare 
services. Nevertheless, despite this lack of conceptual clarity, it is 
doubtful that continuous and sustained ICU care for COVID-19 
patients will be interpreted by the courts as constituting ‘emergency 
medical treatment’.
Because of their abstract nature, constitutional or human rights 
have meaning only when interpreted by the courts in concrete 
situations. The South African Constitutional Court has decided a 
number of cases dealing with access to resources, and a case that is 
pertinent to the present discussion is Government of the Republic of 
South Africa & Others v Grootboom & Others.[21] Grootboom dealt 
with vulnerable persons’ access to housing, which is realisable 
progressively, as is the right of access to healthcare services. In order 
to assess whether the measures to ensure the progressive realisation 
of the right were adequate in this instance, the Constitutional Court 
formulated a ‘reasonableness’ standard which ensures access to 
be ‘comprehensive’, ‘coherent’, ‘balanced’ and ‘flexible’, and ‘non-
discriminatory’[22] as a ‘programme that excludes a significant 
segment of society cannot be said to be reasonable’.[23] Evidently, 
policy decisions on which COVID-19 patients’ access to ICUs are 
based must adhere to the standard of reasonableness. Significantly, 
the Constitutional Court stated that those ‘whose needs are most 
urgent and whose ability to enjoy all rights is therefore most in peril, 
must not be ignored by the measures aimed at achieving realisation 
of the right’.[24] We argue that the need of COVID-19 patients to 
access ICU services is ‘most urgent’ as contemplated by the Court; it 
is literally a life-and-death matter.
The requirement that a ‘programme that excludes a significant 
segment of society cannot be said to be reasonable’ in relation to 
access to ICU facilities is in keeping with the wording of section 
27(1)(a), which guarantees the right of access to healthcare services 
to ‘everyone’. The use of ‘everyone’ in this context may be interpreted 
to mean that decisions on which patients access ICU services 
may not be discriminatory on the basis of their HIV or TB status. 
Furthermore, the rights in the Bill of Rights are considered to be 
interrelated, so the right to life as guaranteed in section 11 of the 
Constitution could be used to argue that as a limitation on TB and 
HIV patients’ access threatens their survival, their right to life is 
unconstitutionally limited.
Section 9 of the Constitution guarantees the right to equality. 
The section enumerates the grounds upon which people may not 
be discriminated against unfairly. The test for determining whether 
law or conduct amounts to unfair discrimination was developed 
in Harksen v Lane NO and Others.[25] First, it must be determined 
whether the law or conduct at issue differentiates between persons. 
If there is differentiation (such as not allowing access of certain 
groups of people to ICU facilities), it must be determined whether the 
differentiation bears a rational connection to a legitimate government 
purpose. Second, it must be considered whether the differentiation 
amounts to discrimination, and whether the discrimination is fair. 
If the differentiation is on a ground listed in section 9(3) of the 
Constitution, then it amounts to discrimination and is presumed to 
be unfair. The word ‘presumed’ indicates that, in the case of a ground 
listed in subsection 9(3), the onus shifts to the person who defends a 
case of discrimination to show that the discrimination indeed was fair. 
If it is not on a ground listed in subsection 9(3), whether or not the 
differentiation is regarded as discrimination depends on the potential 
of the differentiation to impair the human dignity of persons.
Neither TB nor HIV status is a listed ground in section 9(3). 
However, the Constitutional Court in Hoffmann v South African 
Airways[26] held that HIV status amounts to an analogous ground, as 
discrimination on the basis of a person’s HIV status impacts negatively 
on a person’s dignity based on an ‘ill-informed prejudice’. Although 
no case concerning TB status has reached the Constitutional Court, 
the outcome of such an enquiry would probably be similar.
So far, triage guidelines developed in SA, such as those of the 
Critical Care Society of Southern Africa (CCSSA),[27] appear to 
conform to the Constitutional Court’s ‘reasonableness’ standard 
as outlined above. Nevertheless, some literature suggests that, in 
practice, these guidelines are not always adhered to when decisions 
are made regarding who to admit to ICU facilities. A recent study 
found – even in the absence of a health emergency such as COVID-
19 – in a tertiary public hospital in KwaZulu-Natal Province that 
malignancies and HIV positivity increased the chances of ICU refusal 
more than two-fold.[28] This evidence of exclusion of certain classes 
of persons indicates that stigma associated with certain diseases may 
in some instances influence decisions to limit access. In the light of 
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evidence that suggests that well-managed HIV or TB infection on 
their own do not predispose to an increased risk of worse outcomes 
for COVID-19,[29] potential decisions that result in a blanket non-
admission of people living with HIV or TB to ICU facilities will 
clearly amount to unfair discrimination.
The right to equality and the right of access to healthcare services 
in section 27(1)(a) of the Constitution are subject to the general 
limitations clause; section 36 of the Constitution determines that any 
law of general application that attempts to limit a constitutional right 
must be ‘reasonable and justifiable in an open and democratic society 
based on dignity, equality and freedom’. Furthermore, it dictates 
that an inquiry into whether a limitation is justifiable includes a 
proportionality assessment, referencing factors such as the nature 
of the right, the purpose of the limitation, the extent to which it 
limits the right in question, and whether it is possible to achieve 
the purpose of the limitation in a less restrictive manner. Applying 
the proportionality assessment to criteria for ICU admission, these 
criteria would pass constitutional muster only if they are proportional 
to the aims supporting the restriction and therefore do not unfairly 
limit any of the constitutional rights outlined above.
Clinical facts and associated medical criteria alone are relevant in 
determining whether or not a particular person qualifies for access 
to ICU in specific circumstances, such as the COVID-19 pandemic. 
In this context, Pieterse[30] states: ‘most societies increasingly contend 
that rationing decisions and processes should be based on visible 
and consistent criteria, should be capable of rational justification and 
should be subjected to objective scrutiny, so as to ensure that they 
resonate with values of accountability, equity and fairness’.
Ethical considerations
Apart from the legal considerations, selection of patients for critical 
care in the context of resource limitations is fraught with ethical 
complexity. As such, it must be guided by sound principles. It is well 
accepted that considerations of individual autonomy, reflected here by 
the individual’s wish to be given potentially life-saving treatment, may 
be limited in times of pandemic outbreaks of disease. Nevertheless, 
while individual rights may become subservient to the greater good, 
any limitation has to be aligned with human rights considerations 
and be judged to be necessary, reasonable, proportional, equitable and 
non-discriminatory.[31] Triage during disaster situations is therefore 
based on the principle of distributive justice. Accordingly, scare 
resources are reserved for patients with life-threatening conditions, 
with priority given to those who are predicted to have the best chance 
of survival as a result of treatment.[32]
In particular, distributive justice requires that fairness is integral 
to prioritisation strategies. Should the pandemic escalate in SA, 
decision-making regarding the allocation of scarce critical care 
resources will occur at two main points: firstly, access to ICU care or 
ventilation, and subsequently if withdrawal of ventilation becomes 
necessary based on clinical deterioration or futility.[33] Access to 
ICU care itself may be decided at the primary care level in referral 
hospitals or clinics (when a patient deemed suitable for ICU care is 
intubated) or in a tertiary hospital COVID-19 ward when a stable 
patient suddenly deteriorates and must be considered for transfer 
to the ICU. Different sets of criteria may be necessary – one that 
guides quick decision-making prior to intubation by a primary care/
emergency care doctor, and another that allows a slower decision-
making process using detailed criteria (such as those proposed by 
the CCSSA[27]) in a patient being monitored in a tertiary hospital. 
At all three points, decisions will be made around patients with HIV 
infection or TB.
The moral legitimacy that priority-setting enjoys in the context of 
a public health crisis has as much to do with the criteria selected as 
the process that is followed. Since the COVID-19 outbreak, several 
resource allocation frameworks have been proposed globally.[10,34-39] 
To date, various frameworks have taken different approaches to ICU 
admission criteria, ranging from broad principles excluding those 
least likely to survive based on evidence and clinician experience[40] 
to detailed scoring systems that aim for objectivity at the cost of 
time inefficiency.[27] In both scenarios, a detailed clinic history and 
examination will be needed to screen for comorbidity and possible 
poor prognostic indicators. Given the large number of people 
with undiagnosed hypertension and underlying infections, accurate 
assessment of risk will be challenging.
Regarding the process followed in fair allocation guidance, Norman 
Daniels[41] described an approach to rationing several years ago, 
referred to as the ‘Accountability for Reasonableness’ (A4R) approach. 
While this approach has been widely used in dialysis programmes 
and other limited-resource prioritisation, it has relevance to resource 
rationing necessitated by the COVID-19 pandemic. Central to this 
approach is that decision-making for a priority-setting process be 
based on evidence, principles and values. Given the fact that there 
may be differing conceptions about which principles should inform 
the process, Daniels proposes three key elements of a fair process: the 
basis for decisions should be transparent; decisions should be based 
on motivations that are deemed relevant to meeting health needs 
fairly; and procedures should be in place to revise decisions when 
they are challenged.[41]
Where HIV and TB are concerned, clinical evidence for inclusion 
or exclusion from ventilation must guide rationing frameworks.[29] 
Similar to other patients, criteria around comorbidities and prognosis 
will apply. The CCSSA framework, while silent on exclusion or 
inclusion criteria for TB, is specific that HIV-infected patients will 
be considered for admission to an ICU unless there is the presence 
of an AIDS-defining illness, a CD4+ count <50 cells/µL in untreated 
patients, or an HIV viral load >10 000 copies/mL in treated patients. 
It is essential that guidelines be evidence based and not unfairly 
exclude patients who may benefit from treatment. Public health 
measures that involve significant costs and/or burdens, such as 
limiting ICU access, should be backed up by sound evidence.[42] In 
this regard, it should be noted that while the two former criteria 
proposed by the CCSSA framework have been associated with an 
increased risk of ICU mortality,[43] HIV viral load has not.[44] A high 
viral load could be a sign of an inadequate treatment regimen, drug 
interactions, treatment interruption due to non-adherence or drug 
toxicity, or the presence of drug resistance. Since all of these scenarios 
are manageable, and since a single viral load measurement is not 
associated with mortality, we argue that this criterion should not be 
considered when assessing ICU eligibility.
Given the paucity of evidence on prognosis in patients with HIV 
and TB in the context of COVID-19 in the SA setting, guidelines 
could warrant revision and adjustment in subsequent weeks. In 
addition, the scientific evidence is constantly evolving, and at the 
time of writing, concerns were being raised that invasive ventilation 
may not always be associated with good outcomes,[45] as had also 
been reported previously in studies evaluating the management of 
acute respiratory distress syndrome.[46] As such, decisions have to 
be revisited in light of emerging evidence. Transparency around 
the grounds for decision-making, strongly supported by the A4R 
approach, would be imperative. Transparency is important to 
afford civil society the opportunity to engage with guidelines, and 
to challenge and revise decisions under normal circumstances. 
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However, in the context of a pandemic surge, an appeals mechanism 
may be logistically challenging.[33]
Conclusions
Rationing of ICU admission and care will be inevitable if the COVID-
19 pandemic expands as predicted. In the context of limited resources, 
coupled with high levels of vulnerability in the SA population, ICU 
admission criteria need to be carefully scrutinised for their ethical 
and legal robustness. All allocation and rationing decisions must 
be in terms of SA law, which prohibits unfair discrimination. In 
addition, ethical decision-making demands accurate and evidence-
based strategies for the fair distribution of limited resources. There 
is no evidence at this early stage of the epidemic suggesting that 
HIV or TB infection on their own will predispose people to an 
increased risk of infection with SARS-CoV-2 or worse outcomes 
for COVID-19. It will therefore be unconstitutional and unethical 
to deny people ICU access based purely on the presence of these 
infections. We recommend that protocols for determining eligibility 
for intensive care focus on validated disease-specific scoring systems, 
with the caveat that these may change as the epidemic unfolds in SA. 
Rationing decisions and processes should be fair and based on visible 
and consistent criteria that can be subjected to objective scrutiny, 
with the ultimate aim of ensuring accountability, equity and fairness.
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